S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in
NYSE:IVC

Invacare Competitors

$9.92
-0.01 (-0.10 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.64
Now: $9.92
$10.02
50-Day Range
$8.27
MA: $9.29
$10.40
52-Week Range
$3.90
Now: $9.92
$10.74
Volume93,495 shs
Average Volume178,020 shs
Market Capitalization$341.43 million
P/E RatioN/A
Dividend YieldN/A
Beta0.94

Competitors

Invacare (NYSE:IVC) Vs. ABT, MDT, SYK, ISRG, BDX, and EW

Should you be buying IVC stock or one of its competitors? Companies in the sub-industry of "health care equipment" are considered alternatives and competitors to Invacare, including Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), and Edwards Lifesciences (EW).

Invacare (NYSE:IVC) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Profitability

This table compares Invacare and Abbott Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invacare-4.87%-8.76%-3.07%
Abbott Laboratories10.50%18.19%8.29%

Insider & Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 72.6% of Abbott Laboratories shares are owned by institutional investors. 3.2% of Invacare shares are owned by insiders. Comparatively, 1.7% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for Invacare and Abbott Laboratories, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invacare00203.00
Abbott Laboratories121302.75

Invacare currently has a consensus target price of $14.00, indicating a potential upside of 41.13%. Abbott Laboratories has a consensus target price of $115.6875, indicating a potential upside of 0.84%. Given Invacare's stronger consensus rating and higher possible upside, research analysts clearly believe Invacare is more favorable than Abbott Laboratories.

Risk & Volatility

Invacare has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

Valuation & Earnings

This table compares Invacare and Abbott Laboratories' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invacare$927.96 million0.37$-53,330,000.00($1.06)-9.36
Abbott Laboratories$31.90 billion6.37$3.69 billion$3.2435.41

Abbott Laboratories has higher revenue and earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Summary

Abbott Laboratories beats Invacare on 9 of the 14 factors compared between the two stocks.

Invacare (NYSE:IVC) and Medtronic (NYSE:MDT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Profitability

This table compares Invacare and Medtronic's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invacare-4.87%-8.76%-3.07%
Medtronic12.69%9.71%5.30%

Risk & Volatility

Invacare has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.

Insider & Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 79.2% of Medtronic shares are owned by institutional investors. 3.2% of Invacare shares are owned by insiders. Comparatively, 0.5% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for Invacare and Medtronic, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invacare00203.00
Medtronic032012.92

Invacare currently has a consensus target price of $14.00, indicating a potential upside of 41.13%. Medtronic has a consensus target price of $122.2963, indicating a potential upside of 4.62%. Given Invacare's stronger consensus rating and higher possible upside, research analysts clearly believe Invacare is more favorable than Medtronic.

Valuation & Earnings

This table compares Invacare and Medtronic's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invacare$927.96 million0.37$-53,330,000.00($1.06)-9.36
Medtronic$28.91 billion5.44$4.79 billion$4.5925.47

Medtronic has higher revenue and earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Summary

Medtronic beats Invacare on 10 of the 15 factors compared between the two stocks.

Invacare (NYSE:IVC) and Stryker (NYSE:SYK) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Profitability

This table compares Invacare and Stryker's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invacare-4.87%-8.76%-3.07%
Stryker12.35%20.94%8.77%

Volatility & Risk

Invacare has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Insider and Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 71.5% of Stryker shares are owned by institutional investors. 3.2% of Invacare shares are owned by company insiders. Comparatively, 6.8% of Stryker shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Invacare and Stryker, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invacare00203.00
Stryker271412.58

Invacare currently has a consensus target price of $14.00, indicating a potential upside of 41.13%. Stryker has a consensus target price of $227.4783, indicating a potential downside of 5.04%. Given Invacare's stronger consensus rating and higher possible upside, equities analysts plainly believe Invacare is more favorable than Stryker.

Valuation and Earnings

This table compares Invacare and Stryker's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invacare$927.96 million0.37$-53,330,000.00($1.06)-9.36
Stryker$14.88 billion6.05$2.08 billion$8.2629.00

Stryker has higher revenue and earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Summary

Stryker beats Invacare on 11 of the 15 factors compared between the two stocks.

Invacare (NYSE:IVC) and Intuitive Surgical (NASDAQ:ISRG) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Profitability

This table compares Invacare and Intuitive Surgical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invacare-4.87%-8.76%-3.07%
Intuitive Surgical24.45%12.08%10.44%

Volatility & Risk

Invacare has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Insider and Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 86.5% of Intuitive Surgical shares are owned by institutional investors. 3.2% of Invacare shares are owned by company insiders. Comparatively, 1.6% of Intuitive Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Invacare and Intuitive Surgical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invacare00203.00
Intuitive Surgical381002.33

Invacare currently has a consensus target price of $14.00, indicating a potential upside of 41.13%. Intuitive Surgical has a consensus target price of $736.0588, indicating a potential downside of 2.12%. Given Invacare's stronger consensus rating and higher possible upside, equities analysts plainly believe Invacare is more favorable than Intuitive Surgical.

Valuation and Earnings

This table compares Invacare and Intuitive Surgical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invacare$927.96 million0.37$-53,330,000.00($1.06)-9.36
Intuitive Surgical$4.48 billion19.74$1.38 billion$9.9575.58

Intuitive Surgical has higher revenue and earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Summary

Intuitive Surgical beats Invacare on 10 of the 14 factors compared between the two stocks.

Invacare (NYSE:IVC) and Becton, Dickinson and (NYSE:BDX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Profitability

This table compares Invacare and Becton, Dickinson and's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invacare-4.87%-8.76%-3.07%
Becton, Dickinson and5.11%13.30%5.60%

Volatility & Risk

Invacare has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Becton, Dickinson and has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500.

Insider and Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 83.2% of Becton, Dickinson and shares are owned by institutional investors. 3.2% of Invacare shares are owned by company insiders. Comparatively, 0.8% of Becton, Dickinson and shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Invacare and Becton, Dickinson and, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invacare00203.00
Becton, Dickinson and07702.50

Invacare currently has a consensus target price of $14.00, indicating a potential upside of 41.13%. Becton, Dickinson and has a consensus target price of $279.6667, indicating a potential upside of 7.46%. Given Invacare's stronger consensus rating and higher possible upside, equities analysts plainly believe Invacare is more favorable than Becton, Dickinson and.

Valuation and Earnings

This table compares Invacare and Becton, Dickinson and's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invacare$927.96 million0.37$-53,330,000.00($1.06)-9.36
Becton, Dickinson and$17.12 billion4.42$874 million$10.2025.51

Becton, Dickinson and has higher revenue and earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than Becton, Dickinson and, indicating that it is currently the more affordable of the two stocks.

Summary

Becton, Dickinson and beats Invacare on 9 of the 14 factors compared between the two stocks.

Invacare (NYSE:IVC) and Edwards Lifesciences (NYSE:EW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Profitability

This table compares Invacare and Edwards Lifesciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invacare-4.87%-8.76%-3.07%
Edwards Lifesciences18.18%29.00%18.10%

Volatility & Risk

Invacare has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.

Insider and Institutional Ownership

96.7% of Invacare shares are owned by institutional investors. Comparatively, 80.9% of Edwards Lifesciences shares are owned by institutional investors. 3.2% of Invacare shares are owned by company insiders. Comparatively, 1.5% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Invacare and Edwards Lifesciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invacare00203.00
Edwards Lifesciences271202.48

Invacare currently has a consensus target price of $14.00, indicating a potential upside of 41.13%. Edwards Lifesciences has a consensus target price of $90.8704, indicating a potential upside of 5.80%. Given Invacare's stronger consensus rating and higher possible upside, equities analysts plainly believe Invacare is more favorable than Edwards Lifesciences.

Valuation and Earnings

This table compares Invacare and Edwards Lifesciences' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invacare$927.96 million0.37$-53,330,000.00($1.06)-9.36
Edwards Lifesciences$4.35 billion12.31$1.05 billion$1.8646.18

Edwards Lifesciences has higher revenue and earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Summary

Edwards Lifesciences beats Invacare on 10 of the 14 factors compared between the two stocks.


Invacare Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Abbott Laboratories logo
ABT
Abbott Laboratories
2.4$114.72-1.6%$203.33 billion$31.90 billion60.70Upcoming Earnings
Medtronic logo
MDT
Medtronic
2.7$116.90-0.3%$157.35 billion$28.91 billion44.62
Stryker logo
SYK
Stryker
2.0$239.55-0.2%$90.02 billion$14.88 billion51.96Upcoming Earnings
Intuitive Surgical logo
ISRG
Intuitive Surgical
1.7$752.01-1.1%$88.40 billion$4.48 billion85.65Earnings Announcement
Becton, Dickinson and logo
BDX
Becton, Dickinson and
2.0$260.24-0.6%$75.69 billion$17.12 billion95.33Dividend Announcement
News Coverage
Edwards Lifesciences logo
EW
Edwards Lifesciences
1.6$85.89-0.4%$53.53 billion$4.35 billion68.71Upcoming Earnings
Boston Scientific logo
BSX
Boston Scientific
2.2$36.78-0.7%$52.67 billion$10.74 billion14.09
IDEXX Laboratories logo
IDXX
IDEXX Laboratories
1.5$489.21-0.7%$41.73 billion$2.41 billion85.23Upcoming Earnings
Baxter International logo
BAX
Baxter International
2.3$80.10-0.7%$40.92 billion$11.36 billion45.51
DexCom logo
DXCM
DexCom
1.9$376.39-1.7%$36.14 billion$1.48 billion155.53Insider Selling
ResMed logo
RMD
ResMed
1.4$221.68-2.8%$32.12 billion$2.96 billion47.57Upcoming Earnings
Hologic logo
HOLX
Hologic
1.9$76.34-0.8%$19.62 billion$3.78 billion18.18Upcoming Earnings
Insulet logo
PODD
Insulet
1.3$288.91-0.5%$19.05 billion$738.20 million656.63
Teleflex logo
TFX
Teleflex
2.0$382.14-1.1%$17.80 billion$2.60 billion49.18
STERIS logo
STE
STERIS
2.1$190.41-0.9%$16.25 billion$3.03 billion38.62Upcoming Earnings
Varian Medical Systems logo
VAR
Varian Medical Systems
1.3$175.33-0.1%$16.02 billion$3.17 billion59.84
Abiomed logo
ABMD
Abiomed
1.5$348.32-0.1%$15.74 billion$840.88 million76.55Upcoming Earnings
Masimo logo
MASI
Masimo
1.4$257.09-2.6%$14.15 billion$937.84 million66.78
Hill-Rom logo
HRC
Hill-Rom
2.0$101.16-1.7%$6.71 billion$2.88 billion30.47
Globus Medical logo
GMED
Globus Medical
1.4$64.44-1.4%$6.36 billion$785.37 million70.04
Integra LifeSciences logo
IART
Integra LifeSciences
1.4$69.36-0.1%$5.85 billion$1.52 billion103.52
NuVasive logo
NUVA
NuVasive
1.5$56.80-0.2%$2.91 billion$1.17 billion-258.18
AtriCure logo
ATRC
AtriCure
1.3$58.30-1.3%$2.62 billion$230.81 million-50.70
Integer logo
ITGR
Integer
2.3$78.15-1.2%$2.57 billion$1.26 billion35.52
Cardiovascular Systems logo
CSII
Cardiovascular Systems
1.3$46.51-0.3%$1.87 billion$236.54 million-70.47
Alphatec logo
ATEC
Alphatec
0.8$14.92-0.7%$1.17 billion$113.43 million-13.56
CryoLife logo
CRY
CryoLife
1.5$24.96-1.2%$969.87 million$276.22 million-65.68
Orthofix Medical logo
OFIX
Orthofix Medical
1.2$44.94-2.2%$868.77 million$459.95 million37.45
AngioDynamics logo
ANGO
AngioDynamics
1.6$18.55-1.9%$704.04 million$264.16 million-4.15
Surmodics logo
SRDX
Surmodics
1.5$46.33-1.0%$633.89 million$94.86 million579.13News Coverage
Accuray logo
ARAY
Accuray
2.2$5.08-0.6%$463.67 million$382.93 million36.29Upcoming Earnings
Rockwell Medical logo
RMTI
Rockwell Medical
1.3$1.46-2.7%$136.62 million$61.30 million-3.40
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.